Senior Medical DirectorHemab Therapeutics41 King George Square, Richmond, England, United Kingdom
PB1291 - A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia
Tuesday, June 25, 202413:45 – 14:45 ICT